AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
Josh Golomb is a Partner on OrbiMed's Public Equity team focusing on biotechnology, and he joined the firm in 2021. He has more than 20 years of investment experience in biotechnology and pharmaceuticals. Before OrbiMed, he was a Senior Analyst covering biotech and pharmaceuticals at HealthCor Management and held buyside analyst roles at Millennium, Citadel, Diamondback and ProMed.
Notable companies
Selected portfolio companies the partner has backed
The Biotech Growth Trust
Background
Career, education, and skills
Career history
- OrbiMedPartner, Public Equity Team2021 – Present
- HealthCor ManagementSenior Analyst, Biotech and Pharmaceuticals
- MillenniumBuyside Analyst
- CitadelBuyside Analyst
- DiamondbackBuyside Analyst
- ProMedBuyside Analyst
Education
- Fu Foundation School of Engineering and Applied Science, Columbia UniversityB.S. in Operations Research, concentration in Engineering Management Systems
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.